Taking tamoxifen to prevent breast cancer can save lives and money

	Tweet

Tamoxifen, taken by certain women as a preventive measure against breast cancer, saves lives and reduces medical costs. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study’s results suggest that the benefits of tamoxifen to prevent cancer can sufficiently compensate for its side effects in post-menopausal women under age 55 years who have an increased risk of developing breast cancer.

Research has shown that tamoxifen can protect against breast cancer for years after treatment ends, but identifying the group of women who can most benefit from the drug as a cancer preventive agent, without experiencing serious side effects, is a challenge. Side effects of the drug can include Pulmonary embolism, endometrial cancer, deep vein thrombosis, and cataracts, as well as hot flashes and early menopause.

To investigate those women who would benefit the most from taking tamoxifen as a cancer preventive drug, Peter Alperin, MD, of Archimedes Inc. in San Francisco, and his colleagues used a mathematical model to simulate a post-menopausal population under age 55 years in a virtual clinical trial comparing tamoxifen treatment with no treatment.

The investigators modeled tamoxifen therapy based on an analysis of four randomized, placebo-controlled cancer prevention trials, and they assessed the effects that tamoxifen would have on women’s breast cancer risk for 10 years following the end of treatment. Cancer incidences and survival information were taken from the Surveillance Epidemiology and End Results cancer registry, while factors such as non-cancer disease incidences, quality of life, and costs were taken from the medical literature.

The researchers found that in post-menopausal women ages 55 years and younger with a 5-year risk of developing breast cancer of 1.66 percent or greater, the benefits of tamoxifen are maximized while its side effects are minimized. “In this group of women, using tamoxifen to prevent breast cancer saves lives and has a low frequency of side effects,” said Dr. Alperin. He added that it also saves medical costs. “Specifically, chemoprevention with tamoxifen prevents 29 breast cancer cases and 9 breast cancer deaths per 1,000 women treated, and it saves $47,580 per 1,000 women treated in the United States.”

These findings may help physicians and their patients as they strive to identify optimal breast cancer prevention options for individual women based on their current health and demographic profile. In addition, investigators can use mathematical modeling and cost-effectiveness analyses, such as those described in this study, to explore different prevention strategies and evaluate their impact on health and economic outcomes.

###

Contact: Jennifer Beal

44-012-437-70633
Wiley-Blackwell

RELATED STORIES:
Research advances breast reconstruction   Chemotherapy-induced anemia increases risk of local breast cancer recurrence   Minorities less likely to know about breast cancer options   Hormone Sensitivity of Breast Stem Cells Presents Drug Target   Early investigations promising for detecting metastatic breast cancer cells   Blood Protein Detects Lung Cancer, Even at Earliest Stage   Combination therapy reduced HER2-positive breast cancers   How to Eat Healthy to Help Prevent Breast Cancer   Scott & White Healthcare pathologist is co-investigator on breast cancer study   New leaflet offers breast cancer help   New approach to treating breast cancer uses existing chemo drug   Tumor-free breast tissue can have precancerous changes   External-beam radiation therapy safe for breast cancer   Alcohol may raise chances of breast cancer return   Biomarker May Be an Early Predictor of Advanced Breast Cancer   Large breast cancers persist despite screening   Breast cancer survivors struggle with cognitive problems several years after treatment   Breast Cancer Patients with Greater Need Seek More Information Online   Study identifies women with breast cancer most likely to benefit from aromatase inhibitor   Racial Differences in Breast Cancer Treatment Persist, Despite Similar Economics   Untangling the development of breast cancer   Virus spread by sex is linked to breast cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]